Author

Na Chen

Observed name: NA Chen

OpenAlex ID: A5075167478

Penpulimab, an Fc-Engineered IgG1 Anti-PD-1 Antibody, With Improved Efficacy and Low Incidence of Immune-Related Adverse Events

2022 · Zhaoliang Huang, Xinghua Pang, et al. · Frontiers in Immunology · 44

266 AK117, a CD47 blocking antibody with robust macrophage activation without red blood cell hemagglutination

2021 · Zhaoliang Huang, Xinghua Pang, et al. · Journal for ImmunoTherapy of Cancer · 2

702 Dual blockade of the PD-1 checkpoint pathway and the adenosinergic negative feedback signaling pathway with a PD-1/CD73 bispecific antibody for cancer immune therapy

2020 · Tingting Zhong, Zhaoliang Huang, et al. · Journal for ImmunoTherapy of Cancer · 2

Abstract 3827: Bispecific antibodies with an anti-PD-1 backbone for cancer therapy generate enhanced immune activity

2018 · Baiyong Li, Zhaoliang Huang, et al. · Cancer Research · 1

Works count: 4

Citation count: 49

H-index: 2

I10-index: 1